Investing Profile

Jerome Wittamer(137)

Photo of Jerome Wittamer, Managing Partner at Expon Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

11 Investors

Connected to Gigi Levy-Weiss (NFX), Brad Feld (Foundry Group), David Mort (Propel Venture Partners), and 8 other investors on Signal.

cb
Expon Capital Managing Partner
$250K - $4.0M
$350K
20
CompanyStageDateRound SizeTotal Raised
Series AOct 2019$13M
$29M
Co-investors: Jon Callaghan (True Ventures), Saul Klein (LocalGlobe), Keith Teare (Archimedes Accelerator LLC), Rodrigo SEPULVEDA SCHULZ (Expon Capital), Matt Mullenweg (Audrey Capital), David Fogel (Alma Angels), Niklas Zennström (Atomico)
Series AOct 2019
Co-investors: Rodrigo SEPULVEDA SCHULZ (Expon Capital)
Series DSep 2019$40M
Series CNov 2017$70M
$160M
Co-investors: Helen Zelman Boniske (Lemnos Labs), Lewis Jones (Seraphim Capital), Jeff Crusey (Seraphim Capital), Rodrigo SEPULVEDA SCHULZ (Expon Capital), Paul Sims
Series AJul 2019$34M
$34M
Co-investors: Rodrigo SEPULVEDA SCHULZ (Expon Capital)
Convertible NoteJun 2019
$4.6M
Co-investors: Rodrigo SEPULVEDA SCHULZ (Expon Capital), Patrick Chung (Xfund), Pravin Vazirani (Owl Rock Capital Partners), Ullas Naik (Streamlined Ventures)
Venture RoundMay 2019$5.3M
$8.8M
Co-investors: Alan Patricof (Greycroft), Bernardo Hernandez (e.ventures), Adeyemi Ajao (Base10 Partners), Adam Draper (BoostVC), Rodrigo SEPULVEDA SCHULZ (Expon Capital), Charlie Songhurst, Peter Pastewka, Greg Kidd
Series DApr 2019$169M
$199M
€7M
Co-investors: Bernardo Hernandez (e.ventures), Rodrigo SEPULVEDA SCHULZ (Expon Capital), Simon Wu (Cathay Innovation), Edoardo Bianchi
Convertible NoteApr 2019
Co-investors: Rodrigo SEPULVEDA SCHULZ (Expon Capital)
Discovered smthg extraordinary improving lives? Uncovered a secret that seamlessly unites people and machines? Making technology fluid & disappear?
Don't bother with me too's, tech without super competitive edge, unambitious people with no strong vision. I don't do biotech/pharma/gambling...
Rotterdam School of Management, Erasmus University MBA